Friday, July 10, 2026

pharma · Hepatocellular Carcinoma · Liver Cancer

Chinese PLA General

Chinese PLA General trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
4
Drugs
9
Patents
0
Intelligence · Clinical Trials

Chinese PLA General clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Chinese PLA General programs — each row shows trial ID, program name, phase, status, and indication.

Chinese PLA General trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Chinese PLA General.

  1. raltitrexed combined with apatinib — Phase 2

    Clinical update
  2. Chemotherapy drug — Phase 3

    Clinical update
  3. anti-CD133-CAR vector-transduced T cells — Phase 2

    Clinical update
  4. adoptive immunotherapy — Phase 3

    Clinical update

Trial registry

4 studies